Interleukin-4 up-regulates T-tropic human immunodeficiency virus type 1 transcription in primary CD4+ CD38+ T-lymphocyte subset

Microbiology and Immunology

Volumn 49, Issue 2, 2005, Pages 155-165

  Li, Yong Gang ^a   Iwabu, Yukie ^a   Warachit, Jiranan ^a   Kinomoto, Masanobu ^a,b   Ibrahim, Madiha S ^a   Tsuji, Shoutaro ^a   Mukai, Tetsu ^b   Kameoka, Masanori ^c   Tokunaga, Kenzo ^b   Sata, Tetsutaro ^b   Ikuta, Kazuyoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

AP 1; CD38; HIV 1; IL 4; Transcription

Indexed keywords

CD38 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; PHYTOHEMAGGLUTININ; STAT6 PROTEIN; TRANSCRIPTION FACTOR AP 1;

ADSORPTION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE PROLIFERATION; NONHUMAN; NORMAL HUMAN; PROGENY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 20144362110     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2005.tb03715.x     Document Type: Article

References (46)

1. Adachi, A., Gendelman, H.E., Koenig, S., Folks, T., Willey, R., Rabson, A., and Martin, M.A. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59: 284-291.
2. Bleul, C.C., Wu, L., Hoxie, J.A., Springer, T.A., and Mackay, C.R. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 94: 1925-1930.
3. Calcaterra, S., Cappiello, G., Di Caro, A., Garbuglia, A.R., and Benedetto, A. 2001. Comparative analysis of total and integrated HIV-1 DNA in peripheral CD4 lymphocytes and monocytes after long treatment with HAART. J. Infect. 43: 239-245.
4. Clerici, M., Hakim, F.T., Venzon, D.J., Blatt, S., Hendrix, C.W., Wynn, T.A., and Shearer, G.M. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91: 759-765.
5. Cullen, B.R. 1991. Regulation of HIV-1 gene expression. FASEB J. 5: 2361-2368.
6. + T cells residing within human lymphoid tissues. Immunity 15: 671-682.
7. Hofmann, B., Nishanian, P., Fahey, J.L., Esmail, I., Jackson, A.L., Detels, R., and Cumberland, W. 1991. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change. Clin. Immunol. Immunopathol. 61: 212-224.
8. + produce interleukin-4 which contributes to enhanced replication of T-tropic human immunodeficiency virus type 1. Virology 293: 94-102.
9. + T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules. Virus Res. 73: 1-16.
10. Ibegbu, C., Spira, T.J., Nesheim, S., Mendez, H., Lee, F., Polliotti, B., Caba, J., and Nahmias, A. 1994. Subpopulations of T and B cells in perinatally HIV-infected and non-infected age-matched children compared with those in adults. Clin. Immunol. Immunopathol. 71: 27-32.
11. Ibrahim, M.S., Watanabe, M., Palacios, J.A., Kamitani, W., Komoto, S., Kobayashi, T., Tomonaga, K., and Ikuta, K. 2002. Varied persistent life cycles of Borna disease virus in a human oligodendroglioma cell line. J. Virol. 76: 3873-3880.
12. Janossy, G., Borthwick, N., and Lomnitzer, R. 1992. Proliferative defects of CD4 and CDS lymphocytes in HIV-1 infection, p. 96-114. In Janossy, G., Autran, B., and Miedema, F. (eds), Immunodeficiency in HIV infection and AIDS, Karger, Basel.
13. - T lymphocytes in HIV infection, p. 195-210. In Janossy, G., Autran, B., and Miedema, F. (eds), Immunodeficiency in HIV infection and AIDS, Karger, Basel.
14. Kameoka, M., Ota, K., Tetsuka, T., Tanaka, Y., Itaya, A., Okamoto, T., and Yoshihara, K. 2000. Evidence for regulation of NF-κB by poly(ADP-ribose) polymerase. Biochem. J. 346: 641-649.
15. Kazazi, F., Mathijs, J.M., Chang, J., Malafiej, P., Lopez, A., Dowton, D., Sorrell, T.C., Vadas, M.A., and Cunningham, A.L. 1992. Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J. Gen. Virol. 73: 941-949.
16. + T lymphocytes during HIV-1 infection. Clin. Exp. Immunol. 95: 436-441.
17. + T cells isolated from HIV-infected individuals in the absence of markers of cellular activation or apoptosis. J. Immunol. 170: 2449-2455.
18. Korin, YD., and Zack, J.A. 1999. Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated GO lymphocytes. J. Virol. 73: 6526-6532.
19. Lee, B., Sharron, M., Montaner, L.J., Weissman, D., and Doms, R.W. 1999. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. U.S.A. 96: 5215-5220.
20. + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16: 83-92.
21. Lund, F.E., Cockayne, D.A., Randall, T.D., Solvason, N., Schuber, F., and Howard, M.C. 1998. CD38: a new paradigm in lymphocyte activation and signal transduction. Immunol. Rev. 161: 79-93.
22. Mahalingam, M., Pozniak, A., McManus, T.J., Vergani, D., and Peakman, M. 1995. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes. Clin. Exp. Immunol. 102: 481-486.
23. Martinez, O.M., Gibbons, R.S., Garovoy, M.R., and Aronson, F.R. 1990. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J. Immunol. 144: 2211-2215.
24. Michael, N.L., Mo, T., Mersouki, A., O'Shaughnessy, M., Oster, C., Burke, D.S., Redfield, R.R., Birx, D.L., and Cassol, S.A. 1995. Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J. Virol. 69: 1868-1877.
25. + lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14: 158-162.
26. Naif, H.M., Li, S., Ho-Shon, M., Mathijs, J.M., Williamson, P., and Cunningham, A.L. 1997. The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication. J. Immunol. 158: 501-511.
27. Phillips, A.N., Sabin, C.A., Elford, J., Bofill, M., Lee, C.A., and Janossy, G. 1993. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. AIDS 7: 975-980.
28. Pierson, T.C., Zhou, Y., Kieffer, T.L., Ruff, C.T., Buck, C., and Siliciano, R.F. 2002. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J. Virol. 76: 8518-8531.
29. + T cells and T cell activation markers in HIV-1 infected children on HAART. Clin. Exp. Immunol. 125: 266-273.
30. Roederer, M., Raju, P.A., Mitra, O.K., Herzenberger, L.A., and Herzenberg, L.A. 1997. HIV does not replicate in naïve CD4 T cells stimulated with CD3/CD28. J. Clin. Invest. 99: 1555-1564.
31. + T cells lacking activation markers support HIV replication during immune activation. J. Immunol. 166: 6437-6443.
32. + memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. U.S.A. 87: 6058-6062.
33. Sousa, A.E., Carneiro, J., Meier-Schellersheim, M., Grossman, Z., and Victorino, R.M. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169: 3400-3406.
34. + T-helper 1 (Th1)- and Th2-type conditions. J. Virol. 73: 316-324.
35. Tedder, T.F., Grain, M.J., Kubagawa, H., Clement, L.T., and Cooper, M.D. 1985. Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases. J. Immunol. 135: 1786-1791.
36. Tobiume, M., Fujinaga, K., Kameoka, M., Kimura, T., Nakaya, T., Yamada, T., and Ikuta, K. 1998. Dependence on host cell cycle for activation of human immunodeficiency virus type 1 gene expression from latency. J. Gen. Virol. 79: 1363-1371.
37. Tokunaga, K., Greenberg, M.L., Morse, M.A., Gumming, R.L., Lyerly, H.K., and Cullen, B.R. 2001. Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates. J. Virol. 75: 6776-6785.
38. Unutmaz, D., KewalRamani, V.N., Marmon, S., and Littman, D.R. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189: 1735-1746.
39. Valentin, A., Lu, W., Rosati, M., Schneider, R., Albert, J., Karlsson, A., and Pavlakis, G.N. 1998. Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc. Natl. Acad. Sci. U.S.A. 95: 8886-8891.
40. Van Lint, C., Amella, C.A., Emiliani, S., John, M., Jie, T., and Verdin, E. 1997. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J. Virol. 71: 6113-6127.
41. van Rij, R.P., Blaak, H., Visser, J.A., Brouwer, M., Rientsma, R., Broersen, S., de Roda Husman, A.M., and Schuitemaker, H. 2000. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. J. Clin. Invest. 106: 1039-1052.
42. Wagner, F., Fischer, N., Lersch, C., Hart, R., and Dancygier, H. 1989. Interleukin 4 inhibits the interleukin 2-induced production of its functional antagonist, interferon γ. Immunol. Lett. 21: 237-241.
43. + T lymphocytes and enhance HIV-1 replication. J. Leukoc. Biol. 64: 642-649.
44. Wong, J.K., Hezareh, M., Gunthard, H.F., Havlir, D.V., Ignacio, C.C., Spina, C.A., and Richman, D.D. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278: 1291-1295.
45. Yang, X., Chen, Y., and Gabuzda, D. 1999. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-κB. J. Biol. Chem. 274: 27981-27988.
46. + T lymphocytes. AIDS 9: 561-566.